Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum Albumine
Phase 2
Withdrawn
- Conditions
- InfertilityIn Vitro Fertilization
- Interventions
- Other: Medium with no human serum albumine addedOther: Conventional medium
- Registration Number
- NCT00541892
- Lead Sponsor
- Sykehuset Telemark
- Brief Summary
The purpose of this study is to determine if a new medium with no human serum albumine added is as good as the media conventionally used for IVF/ICSI.
- Detailed Description
Cells attained in IVF/ICSI procedures are kept in a medium that nurture the cells. Until now all such media have contained human serum albumine. The purpose of this study is to determine if a new medium with no human serum albumine added is as good as the media conventionally used for IVF/ICSI.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Couples seeking IVF/ICSI.
- Female under 38 years of age.
- No more than two previous IVF/ICSI treatments without pregnancy.
- Regular menstruation periods.
- No endocrine disease that requires treatment in the female.
- BMI below 30 in the female.
- At least 8 mature follicles upon monitoring or 6 MII oocytes upon ICSI.
- Written informed consent.
Exclusion Criteria
- Low responders to FSH.
- Females in danger of developing OHSS.
- Sperm sample below ICSI-quality.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Medium with no human serum albumine added Medium with no human serum albumine added 2 Conventional medium Conventional medium
- Primary Outcome Measures
Name Time Method Fertilization 24 hours Cleavage 48 hours Embryo score 48 hours Embryos used 48 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Fertilitetsklinikken Sør
🇳🇴Porsgrunn, Telemark, Norway